當前位置:廣州健侖生物科技有限公司>>生物試劑>>Certest>> 西班牙Certest彎曲桿菌抗體(克隆ECA29)
西班牙Certest彎曲桿菌抗體(克隆ECA29)
廣州健侖生物科技有限公司
廣州健侖長期供應各種生物原料,主要代理品牌:西班牙Certest。
主要產品包括各種生物單克隆抗原抗體、重組蛋白。
西班牙Certest彎曲桿菌抗體(克隆ECA29)
我司還提供其它進口或國產試劑盒:登革熱、瘧疾、流感、A鏈球菌、合胞病毒、腮病毒、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲病、違禁品濫用、肺炎球菌、軍團菌、化妝品檢測、食品安全檢測等試劑盒以及日本生研細菌分型診斷血清、德國SiFin診斷血清、丹麥SSI診斷血清等產品。
歡迎咨詢
歡迎咨詢2042552662
【產品介紹】
貨號 | 產品名稱 | 規格 | 英文名稱 |
MT-18EH30 | 阿米巴原蟲抗體(克隆H30) | x1mg | Anti-Entamoeba Mab (clone EH30) |
MT-25ETV | 腸道病毒VP1重組蛋白 | x1mg | Enterovirus VP1 recombinant protein |
MT-18EV5 | 腸道病毒抗體(克隆EV5) | x1mg | Anti-Enterovirus Mab (clone EV5) |
MT-25STX | 大腸桿菌O157 VT1重組蛋白 | x1mg | E. coli O157 VT1 recombinant protein |
MT-25VT2 | 大腸桿菌O157 VT2重組蛋白 | x1mg | E. coli O157 VT2 recombinant protein |
MT-18E10 | 大腸桿菌O157抗體(克隆E10) | x1mg | Anti-E. coli O157 Mab (clone E10) |
MT-18SN3 | 肺炎鏈球菌單克隆抗體(克隆SN3) | x1mg | Anti-Streptococcus pneumoniae Mab (clone SN3) |
MT-18SN4 | 肺炎鏈球菌單克隆抗體(克隆SN4) | x1mg | Anti-Streptococcus pneumoniae Mab (clone SN4) |
MT-16CP14 | 鈣結合蛋白單克隆抗體(克隆CP14) | x1mg | Anti-Calprotectin Mab (clone CP14) |
MT-18RV3 | 呼吸道合胞病毒單抗(克隆RV3) | x1mg | Anti-RSV Mab (clone RV3) |
MT-18RV4 | 呼吸道合胞病毒單抗(克隆RV4) | x1mg | Anti-RSV Mab (clone RV4) |
MT-25RSV | 呼吸道合胞病毒重組融合蛋白 | x1mg | RSV recombinant fusion protein |
MT-18Y77 | 甲型流感病毒單抗(克隆Y77) | x1mg | Anti-Influenza A Mab (clone Y77) |
MT-25FAN | 甲型流感病毒重組核蛋白 | x1mg | Influenza A recombinant nucleoprotein |
MT-16G18 | 賈第鞭毛蟲抗體(克隆G18) | x1mg | Anti-Giardia Mab trophozoite protein (clone G18) |
MT-16G22 | 賈第鞭毛蟲抗體(克隆G22) | x1mg | Anti-Giardia Mab trophozoite protein (clone G22) |
MT-25A1G | 賈第蟲腸道滋養體重組蛋白 | x1mg | Giardia intestinalis trophozoite recombinant protein |
MT-25GCP | 賈第蟲腸囊菌重組蛋白 | x1mg | Giardia intestinalis cyst recombinant protein |
MT-25GDH | 艱難梭菌GDH重組蛋白 | x1mg | Clostridium difficile GDH recombinant protein |
MT-18TA5 | 艱難梭菌毒素A抗(克隆TA5) | x1mg | Anti-CD Toxin A Mab (clone TA5) |
MT-18TA7 | 艱難梭菌毒素A抗(克隆TA7) | x1mg | Anti-CD Toxin A Mab (clone TA7) |
MT-24TXA | 艱難梭菌毒素A重組蛋白(無毒性片段) | x1mg | C. difficile Toxin A recombinant protein (fragment without toxic activity) |
MT-18TB41 | 艱難梭菌毒素B抗(克隆TB41) | x1mg | Anti-CD Toxin B Mab (clone TB41) |
MT-18TB48 | 艱難梭菌毒素B抗(克隆TB48) | x1mg | Anti-CD Toxin B Mab (clone TB48) |
MT-24TXB | 艱難梭菌毒素B重組蛋白(無毒性片段) | x1mg | C. difficile Toxin B recombinant protein (fragment without toxic activity) |
MT-16GD10 | 艱難梭菌抗體(克隆GD10) | x1mg | Anti-GDH Mab (clone GD10) |
MT-25CEP | 空腸彎曲桿菌重組外膜蛋白 | x1mg | Campylobacter jejuni recombinant outer membrane protein |
MT-26VP6 | 輪狀病毒VP6重組蛋白 | x1mg | Rotavirus VP6 recombinant protein |
MT-16R15 | 輪狀病毒單克隆抗體(克隆R15) | x1mg | Anti-Rotavirus Mab (clone R15) |
MT-28SAGU | 滅活A鏈球菌抗原(天然提取物) | x1mg | Inactivated STREP A antigen (native extract) |
MT-28SEU | 滅活腸炎沙門氏菌抗原(天然提取物) | x1mg | Inactivated Salmonella enteritidis antigen (native extract) |
MT-28SBU | 滅活的鮑氏志賀氏菌抗原(天然提取物) | x1mg | Inactivated Shigella boydii antigen (native extract) |
MT-28EC7U | 滅活的大腸桿菌O157抗原(天然提取物) | x1mg | Inactivated E. coli O157 antigen (native extract) |
MT-28CCU | 滅活的大腸桿菌抗原(天然提取物) | x1mg | Inactivated Campylobacter coli antigen (native extract) |
MT-28LMU | 滅活的單核細胞增生李斯特菌抗原(天然提取物) | x1mg | Inactivated Listeria monocytogenes antigen (native extract) |
MT-28SPNU | 滅活的肺炎鏈球菌抗原(天然提取物) | x1mg | Inactivated Streptococcus pneumoniae antigen (native extract) |
MT-28SFU | 滅活的福氏志賀氏菌抗原(天然提取物) | x1mg | Inactivated Shigella flexneri antigen (native extract) |
MT-28CJU | 滅活的空腸彎曲桿菌抗原(天然提取物) | x1mg | Inactivated Campylobacter jejuni antigen (native extract) |
MT-28SDU | 滅活的痢疾志賀氏菌抗原(天然提取物) | x1mg | Inactivated Shigella dysenteriae antigen (native extract) |
MT-28LNU | 滅活的嗜肺軍團菌抗原(天然提取物) | x1mg | Inactivated Legionella pneumophila antigen (native extract) |
MT-28STMU | 滅活的鼠傷寒沙門氏菌抗原(天然提取物) | x1mg | Inactivated Salmonella typhimurium antigen (native extract) |
MT-28SSU | 滅活的宋內氏志賀菌抗原(天然提取物) | x1mg | Inactivated Shigella sonnei antigen (native extract) |
MT-28PECU | 滅活的幽門螺桿菌抗原(天然提取物) | x1mg | Inactivated H. pylori antigen (native extract) |
MT-29RVV | 滅活呼吸道合胞病毒抗原(天然提取物) | x1mg | Inactivated RSV antigen (native extract) |
MT-28SPAU | 滅活沙門氏菌副傷寒A抗原(天然提取物) | x1mg | Inactivated Salmonella paratyphi A antigen (native extract) |
MT-28SPBU | 滅活沙門氏菌副傷寒B抗原(天然提取物) | x1mg | Inactivated Salmonella paratyphi B antigen (native extract) |
MT-28STU | 滅活傷寒沙門氏菌抗原(天然提取物) | x1mg | Inactivated Salmonella typhi antigen (native extract) |
MT-28YE3U | 滅活小腸結腸炎耶爾森氏菌O:3抗原(天然提取物) | x1mg | Inactivated Yersinia enterocolitica O:3 antigen (native extract) |
MT-28YE9U | 滅活小腸結腸炎耶爾森氏菌O:9抗原(天然提取物) | x1mg | Inactivated Yersinia enterocolitica O:9 antigen (native extract) |
MT-29KOE | 滅活小球隱孢子蟲抗原(天然提取物) | x1mg | Inactivated Cryptosporidium parvum antigen (native extract) |
MT-25EDP | 內阿米巴重組蛋白 | x1mg | Entamoeba dispar recombinant protein |
MT-25NGI1 | 諾如病毒GI.1重組P結構域 | x1mg | Norovirus GI.1 recombinant P domain |
MT-31NGA | 諾如病毒GI.1重組VLP | x1mg | Norovirus GI.1 recombinant VLP |
MT-25NGI3 | 諾如病毒GI.3重組P結構域 | x1mg | Norovirus GI.3 recombinant P domain |
MT-25NGII10 | 諾如病毒GII.10重組P結構域 | x1mg | Norovirus GII.10 recombinant P domain |
MT-25NGII17 | 諾如病毒GII.17重組P結構域 | x1mg | Norovirus GII.17 recombinant P domain |
MT-25NGII14 | 諾如病毒GII.4重組P結構域 | x1mg | Norovirus GII.4 recombinant P domain |
MT-31NPA | 諾如病毒GII.4重組VLP | x1mg | Norovirus GII.4 recombinant VLP |
MT-18NP8 | 諾如病毒GII單克隆抗體(克隆NP8) | x1mg | Anti-Norovirus GII Mab (clone NP8) |
MT-18NG28 | 諾如病毒GI單克隆抗體(克隆NG28) | x1mg | Anti-Norovirus GI Mab (clone NG28) |
MT-25HCP | 人類鈣衛蛋白重組蛋白 | x1mg | Human Calprotectin recombinant protein |
MT-29HLF | 人乳鐵蛋白蛋白質(天然提取物) | x1mg | Human Lactoferrin protein (native extract) |
MT-29HHB | 人血紅蛋白蛋白質(天然提取物) | x1mg | Human Haemoglobin protein (native extract) |
MT-29HTF | 人轉鐵蛋白蛋白質(天然提取物) | x1mg | Human Transferrin protein (native extract) |
MT-20TSS | 溶血性A鏈球菌抗體 | x1mg | Anti-Strep A Pab |
MT-25EHP | 溶組織內阿米巴重組蛋白 | x1mg | Entamoeba histolytica recombinant protein |
MT-16LC16 | 乳鐵蛋白單抗(克隆LC16) | x1mg | Anti-Lactoferrin Mab (clone LC16) |
MT-16LC4 | 乳鐵蛋白單抗(克隆LC4) | x1mg | Anti-Lactoferrin Mab (clone LC4) |
MT-18LN14 | 嗜肺軍團菌單抗(克隆LN14) | x1mg | Anti-Legionella pneumophila Mab (clone LN14) |
MT-18LN29 | 嗜肺軍團菌單抗(克隆LN29) | x1mg | Anti-Legionella pneumophila Mab (clone LN29) |
MT-16CA29 | 彎曲桿菌抗體(克隆ECA29) | x1mg | Anti-Campylobacter Mab (clone CA29) |
MT-25CCP | 彎曲桿菌重組外膜蛋白 | x1mg | Campylobacter coli recombinant outer membrane protein |
MT-25HEX | 腺病毒HEXON重組蛋白 | x1mg | Adenovirus HEXON recombinant protein |
MT-18A14 | 腺病毒單克隆抗體(克隆A14) | x1mg | Anti-Adenovirus Mab (clone A14) |
MT-18A15 | 腺病毒單克隆抗體(克隆A15) | x1mg | Anti-Adenovirus Mab (clone A15) |
MT-18A15 | 腺病毒抗體(克隆A15) | x1mg | Anti-Adenovirus Mab (clone A15) |
MT-25HEXR | 腺病毒六鄰體重組蛋白 | x1mg | Adenovirus HEXON recombinant protein |
MT-18AT18 | 星狀病毒單克隆抗體(克隆AT18) | x1mg | Anti-Astrovirus Mab (clone AT18) |
MT-18AT8 | 星狀病毒單克隆抗體(克隆AT8) | x1mg | Anti-Astrovirus Mab (clone AT8) |
MT-25AST | 星狀病毒衣殼重組蛋白 | x1mg | Astrovirus capsid recombinant protein |
MT-16F22 | 血紅蛋白單抗(克隆F22) | x1mg | Anti-Haemoglobin Mab (clone F22) |
MT-18YB91 | 乙型流感病毒單抗(克隆YB91) | x1mg | Anti-Influenza B Mab (clone YB91) |
MT-25FBN | 乙型流感病毒重組核蛋白 | x1mg | Influenza B recombinant nucleoprotein |
MT-18K31 | 隱球菌抗體(克隆K31) | x1mg | Anti-Crypto Mab (clone K31) |
MT-25PCH | 幽門螺桿菌重組外膜蛋白 | x1mg | H. pylori recombinant outer membrane protein |
MT-16P2 | 幽門螺旋桿菌抗體(克隆P2)HP抗體 | x1mg | Anti-H. pylori Mab (clone P2) |
西班牙Certest彎曲桿菌抗體(克隆ECA29)
托雷茨基與研究合作作者、美國加州拉由拉市斯克利普斯研究所綜合結構和計算生物學學院的皮特·懷特(Peter Wright)教授收集了所有有關集合體的生物物理學和蛋白質生物化學知識并寫成了一篇評論文章。
研究作者表示這些集合體常常,但并非總是由內在紊亂的蛋白質組成,這意味著它們并沒有特定的形狀從而和其它蛋白質形成鎖和鑰匙的匹配關系。這些內在紊亂的蛋白質似乎會集合成一種類似凝膠的集合體——這個過程被稱為“相位分離”,它能夠圍困并與其它蛋白質甚至RNA發生相互作用,RNA能夠幫助編碼和調節基因的生物分子。當它們的工作結束——無論具體是什么——這些集合體便會溶解。
直到近五年研究人員才開始意識到沒有特定結構的蛋白質可能有著重要的轉變特性,它或可能基于在細胞里的存在量而發生改變。托雷茨基懷疑如果這些集合體在疾病方面起著一定的作用,那么它們或可能以小分子為目標。“目前藥物恢復的教條表明制造一個小分子以阻止兩個結構蛋白質的相互作用是非常困難的。然而,小分子擾亂內在紊亂的蛋白質之間的相互作用的可能性則較高。”
“這篇評論將有關蛋白質交互的非常基本的生物學現象與潛在的新藥物研發起來,這真是一項令人興奮的挑戰。” 托雷茨基認為。
**艾滋病病毒和恢復免疫功能的一個zui大障礙是,腸道中穩定的HIV庫。關于早期病毒入侵和腸道病毒庫建立的信息非常少。
現在,加州大學戴維斯分校的研究人員以猿猴免疫缺陷病毒(SIV)為研究對象,在病毒傳染的zui初2.5天內,在腸道中檢測到非常小數量的SIV感染細胞;然而,對病毒的炎癥反應嚴重破壞了腸道內皮細胞。白細胞介素-1β(IL-1β)可減少緊密連接蛋白質的產生,它們對于制造病原體不能透過的腸道屏障至關重要。因此,正常的粘著屏障被打破。
通過深入挖掘,研究人員發現,通過IL-1β生產的炎癥反應是在潘氏細胞內開始的,*這能保護腸道干細胞來補充腸上皮層。這是*報道SIV傳染和IL-1β生產的潘氏細胞傳感,這與早期病毒入侵過程中的腸道上皮損傷有關。反過來,上皮細胞破裂強調,有比免疫細胞更多的免疫反應。
研究人員指出,上皮細胞不僅僅是一道物理屏障,在抵御病毒和細菌的過程中,它為免疫細胞提供支持。
研究人員發現,向腸道添加特定的益生菌菌株——植物乳桿菌,可逆轉IL-1β快速減少所引起的損傷,解決炎癥,并在幾個小時之內加速修復。研究指出了一種有趣的可能性,即利用協同宿主-微生物相互作用來干預早期病毒傳播和腸道炎癥、減輕HIV感染有關的腸道并發癥。
西班牙Certest彎曲桿菌抗體(克隆ECA29)
想了解更多的產品及服務請掃描下方二維碼:
【公司名稱】 廣州健侖生物科技有限公司
【市場部】 楊永漢
【】
【騰訊 】 2042552662
【公司地址】 廣州清華科技園創新基地番禺石樓鎮創啟路63號二期2幢101-103室
Dr. Toretski and co-author of the study, Professor Peter Wright of the Institute of Structural and Computational Biology, Scripps Institution in Lara Luna, Calif., Collected all the biophysics and protein biologies involved in assembly Chemical knowledge and wrote a commentary.
The authors state that these aggregates are often, but not always, composed of intrinsically disorganized proteins, meaning that they do not have a specific shape and thus form a lock-and-key match with other proteins. These intrinsically disorganized proteins appear to assemble into a gel-like assembly - a process known as "phase separation" that can trap and interact with other proteins and even with RNA, which can help genetically encode and regulate genes molecular. When their work is done - no matter what they are - these assemblies dissolve.
It was not until nearly five years that researchers began to realize that proteins without a specific structure may have important transitional properties that may or may not have changed based on the amount present in the cells. Tomatoes suspects that if these aggregates play a role in disease, they may or may target small molecules. "The current dogma of drug recovery shows that it is very difficult to create a small molecule that blocks the interaction of two structural proteins, however, small molecules are more likely to disrupt inner-protein interactions."
"This review is an exciting challenge to relate the very basic biology of protein interactions to potential new drug development," said Torretz.
One of the biggest obstacles to the total eradication of HIV and the restoration of immune function is the stable HIV pool in the gut. There is very little information about early virus invasion and establishment of the gut virus database.
Researchers at the University of California, Davis, now target simian immunodeficiency virus (SIV) and detect very small numbers of SIV-infected cells in the intestine within the first 2.5 days of virus infection; however, The reaction severely damaged the intestinal endothelial cells. Interleukin-1 [beta] (IL-1 [beta]) reduces the production of tight junction proteins that are crucial for the manufacture of an impermeable intestinal barrier to pathogens. Therefore, the normal adhesive barrier is broken.
By digging deeper, the researchers found that the inflammatory response produced by IL-1β started in Paneth cells, which is well-known to protect gut stem cells from replenishing the gut epithelium. This is the first report of Panish cell sensing of SIV infection and IL-1β production, which is associated with intestinal epithelial damage during early viral invasion. In turn, epithelial cell rupture stresses that there are more immune responses than immune cells.
The researchers point out that epithelial cells are more than just a physical barrier, they support immune cells in their defense against viruses and bacteria.
The researchers found that adding a specific probiotic strain, Lactobacillus plantarum, to the intestine reverses the damage caused by a rapid decrease in IL-1β, resolves inflammation and speeds healing within hours. The study points to an interesting possibility of using synergistic host-microbe interactions to intervene in early virus transmission and intestinal inflammation and to reduce the intestinal complications associated with HIV infection.
請輸入賬號
請輸入密碼
請輸驗證碼
以上信息由企業自行提供,信息內容的真實性、準確性和合法性由相關企業負責,智慧城市網對此不承擔任何保證責任。
溫馨提示:為規避購買風險,建議您在購買產品前務必確認供應商資質及產品質量。